Press Releases

AIM Congress Announces 15th Edition for 2026

DUBAI, United Arab Emirates, Oct. 06, 2025 (GLOBE NEWSWIRE) — The Organizing Committee of AIM Congress, the world’s leading investment platform, has officially announced the launch of its 15th edition under the theme: Reshaping Global Prosperity: Unlocking New Investment Pathways Towards a Sustainable and Inclusive Future. AIM Congress will be held from 13 to 15 April 2026 in Dubai World Trade Centre (DWTC), Dubai, United Arab Emirates. His Excellency Dr. Thani bin Ahmed Al Zeyoudi UAE Minister of Foreign Trade AIM Congress, recognized globally as a premier event dedicated to steering sustainable investment trends, will address strategies to navigate major economic transformations. The event aims to explore new horizons for strengthening global partnerships and enabling innovative solutions to address pressing global economic challenges. His Excellency Sultan bin Saeed Al Mansoori Chairman of Dubai Chambers AIM Congress will highlight the critical importance of integrating innovation, sustainability, and inclusivity in building more resilient and adaptable economies capable of sustained growth. In this context, His Excellency Dr. Thani bin Ahmed Al Zeyoudi, UAE Minister of Foreign Trade and President of AIM Congress, stated: “Amid the major global transformations – geopolitical, economic, and technological – it is imperative for nations to build long-term strategies based on resilience, sustainability and diversification. The UAE is pursuing an economy that is not only able to adapt to change but anticipate it, building capabilities in future-focused industries and committing to partnerships with the global growth centers of tomorrow. The outstanding achievements of 2024, which included robust export performance and our continuing rise in global indices as a trusted hub for trade and investment, vindicates our approach. Dawood Al Shezawi President of AIM Global Foundation “The latest edition of AIM Congress is aimed at fostering the collaboration and knowledge exchange between governments, investors, and innovators to further this vision. This year’s Congress focuses

قمة AIM للاستثمار تعلن انطلاق دورتها الخامسة عشرة لعام 2026

دبي، الإمارات العربية المتحدة, Oct. 06, 2025 (GLOBE NEWSWIRE) —  أعلنت اللجنة المنظمة لقمة AIM للاستثمار “منصة الاستثمار الرائدة عالميًا”، عن انطلاق فعاليات دورتها الخامسة عشرة تحت شعار “نحو ازدهار عالمي جديد: إعادة بناء مستقبل الاستثمار لتحقيق التنمية الشاملة والمستدامة”، وذلك خلال الفترة من 13 إلى 15 أبريل 2026، في مركز دبي التجاري العالمي, دبي, الإمارات العربية المتحدة . His Excellency Dr. Thani bin Ahmed Al Zeyoudi UAE Minister of Foreign Trade وتناقش قمة AIM للاستثمار، التي تُعد من أبرز الفعاليات العالمية المعنية بتوجيه مسارات الاستثمار المستدام، سبل التكيّف مع التحولات الاقتصادية الكبرى، واستكشاف آفاق جديدة لتعزيز الشراكات الدولية، وتمكين الحلول الابتكارية لمواجهة تحديات الاقتصاد العالمي. وتُسلّط القمة الضوء على أهمية دمج الابتكار والاستدامة والشمول في بناء اقتصادات أكثر مرونة وقدرة على التكيف والنمو. His Excellency Sultan bin Saeed Al Mansoori Chairman of Dubai Chambers وقال معالي الدكتور ثاني بن أحمد الزيودي وزير التجارة الخارجية، رئيس قمة AIM: “في ظل التحولات العالمية الكبرى، الجيوسياسية والاقتصادية والتكنولوجية، بات من الضروري أن تضع الدول استراتيجيات طويلة الأجل تقوم على المرونة والاستدامة والتنوع الاقتصادي.” Dawood Al Shezawi President of AIM Global Foundation وأضاف معاليه: “تسعى دولة الإمارات إلى بناء اقتصاد لا يكتفي بالتكيف مع التغيرات، بل يتنبأ بها، من خلال تطوير قدراتها في قطاعات اقتصاد المستقبل، وتعزيز شراكاتها مع مراكز النمو الواعدة حول العالم” وأشار معاليه إلى الإنجازات البارزة التي حققتها دولة الإمارات في عام 2024، ومنها -على سبيل المثال- النمو القياسي للصادرات وارتفاع تصنيف الدولة في المؤشرات العالمية كمركز موثوق للتجارة والاستثمار، معتبراً أن هذه النتائج الإيجابية تؤكد صحة هذا النهج. وأكد معالي ثاني الزيودي أن نسخة عام 2026 من قمة AIM تستهدف تعزيز التعاون وتبادل المعرفة بين الحكومات والمستثمرين والمبتكرين لدعم هذه الرؤية، مشيراً إلى أن قمة هذا العام تركز على ثلاثة محاور رئيسية هي: الأسواق العالمية، والاقتصادات المستقبلية، والجيل القادم، وهي ركائز أساسية لبناء اقتصاد قوي ومتوازن للمستقبل، ويعد هذا الحدث السنوي المهم منصة تجمع صناع القرار العالميين وقادة الأعمال والمبتكرين للعمل معاً على صياغة حلول عملية تدعم اقتصادات المستقبل وتعزز جاهزيتنا الجماعية لمواجهة التحديات العالمية. ومن جانبه

North Atlantic France SAS announces the inventory value adjustment amount related to its contemplated acquisition of a majority stake in Esso Société Anonyme Française SA

Paris, FRANCE, Oct. 06, 2025 (GLOBE NEWSWIRE) —  North Atlantic France SAS announces the inventory value adjustment amount related to its contemplated acquisition of a majority stake in Esso Société Anonyme Française SA Paris, FRANCE, October 6, 2025 – North Atlantic France SAS (“North Atlantic”) announced on May 28, 2025, that it had entered into exclusive negotiations with ExxonMobil France Holding SAS (“ExxonMobil”) for the acquisition of ExxonMobil’s entire stake in Esso Société Anonyme Française SA (“Esso S.A.F.”) and ExxonMobil Chemical France SAS by signing a put option agreement. On September 24, 2025, North Atlantic announced the signing of a share purchase agreement. As indicated in these press releases, the purchase price for the acquisition of the stake held by ExxonMobil is subject, among other items, to an upward or downward adjustment reflecting the change in the euro value of Esso S.A.F.’s inventory relative to its value on December 31, 2024. Due to the appreciation of the euro relative to the U.S. dollar and a decline in Brent crude prices, the euro value of Esso S.A.F.’s inventory has decreased. Following the completion by Esso S.A.F. of the transfer of ownership of its crude oil inventory and certain petroleum products to a banking institution, the resulting adjustment is a downward adjustment to the purchase price in an aggregate amount of €141,555,511.67, corresponding to €11.01 per Esso S.A.F. share1. Thus, based on the available information, the price per share of €149.19 would be reduced to €85.18 prior to the payment of any additional distribution and taking into account the following adjustments: adjustment for inventory: downward adjustment of €11.01 per share; cash distributed by Esso S.A.F: downward adjustment of €53.00 per share for the dividend paid by Esso S.A.F. on July 10, 2025. Further, taking into account the contemplated €60.21 per share distribution

Nyxoah Announces First U.S. Commercial Patients Implanted with Genio® System

Nyxoah Announces First U.S. Commercial Patients Implanted with Genio® System Early Commercial Launch Demonstrates Strong Physician Demand, Successful Pre-Authorizations, and Widespread Payor Coverage Mont-Saint-Guibert, Belgium – October 6, 2025 7:00 CET / 1:00 ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA), today announced that the first U.S. commercial patients have been successfully implanted with the Genio® system following FDA approval. “We are thrilled to announce that the first commercial patients have now received Genio implants, marking a significant milestone in bringing this innovative therapy to OSA patients in the U.S.,” said Olivier Taelman, Chief Executive Officer. “Importantly, we have trained surgeons, obtained Value Analysis Committee (VAC) approvals and achieved successful coverage from major payors including CMS. What’s also particularly encouraging is the strong demand we’re seeing from physicians, with surgeons actively reaching out for training opportunities, many of whom already have patients lined up for implants. These early leading indicators give us confidence that we’re building the right foundation for the sustained adoption of Genio moving forward.” Andrew T. Huang, MD FACS, Director of Sleep Surgery at Baylor College of Medicine implanted the first Genio devices at Townsen Memorial Health System in Houston, TX. “I am excited to not only be the first surgeon to perform Genio® implants commercially in the United States but to have completed my first five in one week. It was awesome to see the powerful and symmetric tongue protrusion at the end of each procedure. Like with any new procedure, there is a learning curve, but I’m excited to say the cases took me the same amount of time as my first unilateral HGN implants. The Genio system provides a solution for my patients who do not want two incisions, an implanted

Search

General News